Small-Molecule Xenomycins Inhibit All Stages of the Plasmodium Life Cycle

KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission

(2014) Kelli L. Kuhen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Anticancer Properties of Distinct Antimalarial Drug Classes

(2014) Rob Hooft van Huijsduijnen et al.   PLoS One

Defining the biology component of the drug discovery strategy for malaria eradication

(2014) Didier Leroy et al.   TRENDS IN PARASITOLOGY

Designing the next generation of medicines for malaria control and eradication

(2013) Jeremy N Burrows et al.   MALARIA JOURNAL

Targeting Plasmodium PI(4)K to eliminate malaria

(2013) Case W. McNamara et al.   NATURE

Hits, leads and drugs against malaria through diversity-oriented synthesis

(2012) Sivaraman Dandapani et al.   Future Medicinal Chemistry

Salivary Gland-Specific P. berghei Reporter Lines Enable Rapid Evaluation of Tissue-Specific Sporozoite Loads in Mosquitoes

(2012) Chandra Ramakrishnan et al.   PLoS One

Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications

(2011) Nickolay Neznanov et al.   CELL CYCLE

Curaxins: Anticancer Compounds That Simultaneously Suppress NF- B and Activate p53 by Targeting FACT

(2011) A. V. Gasparian et al.   Science Translational Medicine

A Research Agenda for Malaria Eradication: Drugs

(2011)   PLOS MEDICINE

Artemisinin resistance on the Thai–Cambodian border

(2009) Shunmay Yeung et al.   LANCET